Free Newsletter
Start-up to offer genome sequencing at bargain rate
After operating in stealth mode for more than two years, Complete Genomics took the wraps off on Monday, announcing plans to offer complete human genome sequencing at the bargain basement rate of $5,000 by the second quarter of 2009. CEO Clifford Reid said that Complete Genome will be the first company that can complete full sequencing for less than $1,000 in material costs.
"For the past two and a half years, Complete Genomics has been reinventing the process of DNA sequencing based on pioneering technology invented by its founders and refined by a team of 100 employees with expertise in DNA engineering, molecular biology, instrumentation, semiconductors and high-performance computing," the company said.
The company is planning to open 10 centers over the next five years able to sequence one million genomes. In recent years a number of companies have been engaged in a race to sequence a complete genome for a price in the low four figures.
- see Complete Genomics' release
- read the report from the San Jose Business Journal
Related Articles:
Biotechs use nanotech in pursuit of $100 sequencing bill
Race for $1,000 genome sequencing heats up
Researchers map the cancer genome
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: